内镜经鼻手术治疗大型与巨大垂体腺瘤的中东单中心经验
本研究回顾80例大型(30-39 mm)与巨大(≥40 mm)垂体腺瘤患者,均采用扩大内镜经蝶入路(EETA)切除。全切除66例(82.5%),近全切除10例(12.5%),次全切除4例(5%);术前视力损害者76.8%、视野缺损者74.1%术后改善。作者认为EETA可作为此类肿瘤的一线安全有效术式。
要点
- EETA治疗大型与巨大垂体腺瘤全切除率达82.5%,近全切除率12.5%。
- 肿瘤更大、多叶形态及更高Knosp评分显著降低全切除可能性。
- 常见并发症为新发垂体功能低下16.4%、永久性尿崩7.5%、脑脊液漏5%。
核心结论
- EETA可作为大型与巨大垂体腺瘤的一线治疗,安全有效,全切除或近全切除率高、视功能改善明显且并发症相对较低。
研究设计与样本
- 单中心回顾性研究,纳入80例大型(30-39 mm)与巨大(≥40 mm)垂体腺瘤患者,均行扩大内镜经蝶入路(EETA)肿瘤切除,平均随访24.2个月。
主要发现
- 全切除66例(82.5%),近全切除10例(12.5%),次全切除4例(5%)。
- 术前视力损害者76.8%、视野缺损者74.1%术后改善。
- 常见并发症为新发垂体功能低下16.4%、永久性尿崩7.5%、脑脊液漏5%;脑膜炎2.5%,死亡3.8%。
关键数值与推荐
- 肿瘤更大、多叶形态及更高Knosp评分显著降低全切除可能性。
临床怎么用
- 对大型与巨大垂体腺瘤可优先考虑EETA,术前应结合肿瘤大小、形态与Knosp评分预判全切除难度并规划围手术期并发症管理。
局限性
- 单中心回顾性设计,样本量80例,随访平均24.2个月,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Surgical treatment of large and giant pituitary adenomas is challenging and associated with higher risk of complications and lower rate of gross total resection. We present our experience with surgical management of large and giant adenomas using the extended endoscopic transsphenoidal approach (EETA). METHODS: A total of 80 patients with large (30-39 mm) and giant (≥40 mm) pituitary adenomas who underwent tumor resection using EETA were studied. Radiologic data, hormonal and visual status, surgical outcomes, complications, and factors affecting the extent of resection were evaluated. RESULTS: Forty-five tumors (56.3%) were classified as large and 35 (43.8%) as giant adenomas. Gross total resection was achieved in 66 patients (82.5%), near-total resection in 10 (12.5%), and subtotal resection in 4 (5%). Preoperative factors including larger tumor size, multilobular shape of tumor, and higher Knosp scores significantly decrease the likelihood of gross total resection. Of patients with preoperative visual acuity impairment and visual field deficit, 76.8% and 74.1%, respectively, experienced improvement after surgery. The most common complications include new pituitary insufficiency (16.4%), permanent diabetes insipidus (7.5%), and cerebrospinal fluid leakage (5%). Two cases of meningitis (2.5%) and 3 deaths (3.8%) occurred in this cohort of patients. Mean follow-up duration was 24.2 months. CONCLUSIONS: EETA can be a safe and efficient approach as the first-line treatment of patients with large and giant pituitary adenomas and is associated with high rates of gross total resection or near-total resection, visual function improvement, and a relatively low rate of complications.
引用
- Fallah N, Taghvaei M, Sadaghiani S, et al. Surgical Outcome of Endoscopic Endonasal Surgery of Large and Giant Pituitary Adenomas: An Institutional Experience from the Middle East. World Neurosurg. 2019. PMID: 31404693. doi:10.1016/j.wneu.2019.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。